256 related articles for article (PubMed ID: 23893090)
21. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma.
Sahyoun M; Azar G; Khoueir Z; Antoun J; Kourie H; Nehme J; Jalkh A
J Glaucoma; 2015; 24(5):383-8. PubMed ID: 25719230
[TBL] [Abstract][Full Text] [Related]
22. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.
Shi L; Yang J; Lin J
BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956
[TBL] [Abstract][Full Text] [Related]
23. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
25. Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials.
Bakri SJ; Moshfeghi DM; Francom S; Rundle AC; Reshef DS; Lee PP; Schaeffer C; Rubio RG; Lai P
Ophthalmology; 2014 May; 121(5):1102-8. PubMed ID: 24393349
[TBL] [Abstract][Full Text] [Related]
26. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
[TBL] [Abstract][Full Text] [Related]
28. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
[TBL] [Abstract][Full Text] [Related]
29. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
30. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
Wolf A; von Jagow B; Ulbig M; Haritoglou C
Ophthalmologica; 2011; 226(2):51-6. PubMed ID: 21546781
[TBL] [Abstract][Full Text] [Related]
31. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
32. Topical bevacizumab for neovascular glaucoma: a pilot study.
Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications.
Liu L; Xu Y; Huang Z; Wang X
BMC Ophthalmol; 2016 May; 16():65. PubMed ID: 27230388
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma.
Tang M; Fu Y; Wang Y; Zheng Z; Fan Y; Sun X; Xu X
BMC Ophthalmol; 2016 Jan; 16():7. PubMed ID: 26749079
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
[TBL] [Abstract][Full Text] [Related]
36. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma.
Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB
Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
39. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
40. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]